News Shire launches potential blockbuster dry eye drug in US Xiidra could be ophthalmology blockbuster.
News Genzyme and AZ fall foul of UK pharma code Companies named in adverts after breaching code of practice.
News Tuneable peptide biotech Parabilis files IPO Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3bn, Parabilis has joined the IPO queue.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
